Logotype for Sitowise Group

Sitowise Group (SITOWS) Q3 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Sitowise Group

Q3 2024 earnings summary

16 Jan, 2026

Executive summary

  • Net sales declined by 8.4% year-over-year to €41.8 million in Q3 2024, with adjusted EBITDA/EBITA margin at 5.8% and organic growth at -10% to -10.5%.

  • Infra and Digital Solutions outperformed their markets in both net sales and profitability, while Buildings and Sweden segments remained weak.

  • Strategic restructuring and resource optimization in Sweden and Buildings, including headcount reductions and temporary layoffs, targeted €3.5 million in annual savings.

  • Acquisition of LandPro Oy completed, and internal AI tool Saga AI launched to enhance efficiency and support strategic initiatives.

  • Order book at €154 million at quarter-end, including €12.5 million in projects on hold, down from €167 million year-over-year.

Financial highlights

  • Adjusted EBITDA/EBITA margin fell to 5.8%, with adjusted EBITA at €2.4 million and operating profit at -€0.2 million.

  • Result for the period was -€1.5 million, and earnings per share was -€0.04.

  • Cash flow from operations improved year-over-year to -€0.3 million.

  • Net debt/adjusted EBITDA increased to 5.0x, equity ratio stable at 44.6%.

  • One-off restructuring costs of €1.2 million in Q3, with expected annual savings of €3.5 million.

Outlook and guidance

  • Q4 expected to remain challenging, especially in Buildings, with market recovery for construction anticipated in H2 2025.

  • Sweden's profitability expected to improve from Q4 onwards; medium- and long-term prospects remain positive, especially for Infra and Digital Solutions.

  • Net sales for 2024 expected to decline, with adjusted EBITA margin below 2023; guidance for 2024 remains unchanged.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more